Arine Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 353

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $30M

  • Investors
  • 11

Arine General Information

Description

Developer of a medication management platform designed to improve health and quality of life. The company's medication optimization platform aggregates and analyzes clinical, social, and behavioral data to identify and address gaps in patient care on behalf of payors and risk-bearing providers, enabling patients to get improved outcomes and lower costs for care.

Contact Information

Website
www.arine.io
Formerly Known As
Akeso
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 595 Market Street
  • Suite 2550
  • San Francisco, CA 94105
  • United States
+1 (833)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Clinics/Outpatient Services
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 595 Market Street
  • Suite 2550
  • San Francisco, CA 94105
  • United States
+1 (833)

Arine Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 24-Jun-2025 $30M Completed Generating Revenue
5. Secondary Transaction - Private 15-Jan-2025 Completed Generating Revenue
4. Secondary Transaction - Private 01-Apr-2023 Completed Generating Revenue
3. Later Stage VC (Series B) 17-Aug-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 21-Oct-2021 $13.6M $13.6M Completed Generating Revenue
1. Debt - PPP 14-Apr-2020 $238K Completed Generating Revenue
To view Arine’s complete valuation and funding history, request access »

Arine Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A-4
Series A-3
Series A-2
Series A-1 785,493 $0.000010 $0.04 $0.5 $0.5 1x $0.5 2.33%
Series A 4,508,357 $0.000010 $0.18 $2.22 $2.22 1x $2.22 13.37%
To view Arine’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Arine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medication management platform designed to improve health and quality of life. The company's medication o
Enterprise Systems (Healthcare)
San Francisco, CA
353 As of 2026

Boston, MA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arine Competitors (5)

One of Arine’s 5 competitors is HealthEdge, a Private Equity-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HealthEdge Private Equity-Backed Boston, MA
Cureatr Formerly VC-backed New York, NY
Veradigm Formerly VC-backed Chicago, IL
Swisslog Healthcare Corporation Buchs, Switzerland
Omnicell Formerly VC-backed Fort Worth, TX
You’re viewing 5 of 5 competitors. Get the full list »

Arine Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Arine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3181594-A1 Treatment recommendation Pending 30-Apr-2020
EP-4143663-A1 Treatment recommendation Pending 30-Apr-2020
EP-4143663-A4 Treatment recommendation Pending 30-Apr-2020
US-20230170065-A1 Treatment recommendation Pending 30-Apr-2020
WO-2021222802-A1 Treatment recommendation Inactive 30-Apr-2020 G16H20/00
To view Arine’s complete patent history, request access »

Arine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arine Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kaiser Permanente Ventures Corporate Venture Capital Minority
Town Hall Ventures Venture Capital Minority
MBX Capital Venture Capital Minority
New Leaf Venture Venture Capital Minority
111 West Capital Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Arine FAQs

  • When was Arine founded?

    Arine was founded in 2017.

  • Where is Arine headquartered?

    Arine is headquartered in San Francisco, CA.

  • What is the size of Arine?

    Arine has 353 total employees.

  • What industry is Arine in?

    Arine’s primary industry is Enterprise Systems (Healthcare).

  • Is Arine a private or public company?

    Arine is a Private company.

  • What is the current valuation of Arine?

    The current valuation of Arine is .

  • What is Arine’s current revenue?

    The current revenue for Arine is .

  • How much funding has Arine raised over time?

    Arine has raised $63.6M.

  • Who are Arine’s investors?

    Kaiser Permanente Ventures, Town Hall Ventures, MBX Capital, New Leaf Venture, and 111 West Capital are 5 of 11 investors who have invested in Arine.

  • Who are Arine’s competitors?

    HealthEdge, Cureatr, Veradigm, Swisslog Healthcare, and Omnicell are competitors of Arine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process